London, UK (PRWEB UK) 12 August 2013
On June 17th, Sanofi Pasteur, the vaccines division of Sanofi, announced the launch of Headfirst! Expert Advice on Lice, an educational programme to help expand understanding of head lice infestation and how to approach treatment. Headfirst! Expert Panellist and paediatric dermatologist, Nanette B. Silverberg, MD, FAAD, FAAP, commented, “There are common myths and misconceptions about head lice that may impact how parents react to an infestation and manage the condition. The Headfirst! Expert Panel was assembled to help empower parents dealing with lice and offer expert advice to help them manage and successfully treat it with confidence.” (http://www.prnewswire.com/news-releases/leading-experts-in-parenting-education-and-medicine-partner-to-launch-head-lice-awareness-initiative-211795891.html)
With this in mind, Yourwellness Magazine explored head lice treatments. According to Yourwellness Magazine, “Head lice don’t only affect the wellness of your little ones. Just by coming into contact with your child, entire family wellness can suffer from the dreaded head lice and treating it can be a pain in the neck.” (http://www.yourwellness.com/2013/01/is-the-head-lice-treatment-you-use-this-nice-and-easy/#sthash.XmlCqlmY.dpuf)
Yourwellness Magazine commented that a drug called ivermectin (Sklice) could save parents a lot of time and effort combing through their children’s hair, as it eliminates lice after just one application without the need for nit combing. Yourwellness Magazine reported that ivermectin lotion cleared 94.9% of patients of lice one day after treatment, compared to 31.3% of the controls. They also noted that Sklice was approved by the FDA in February 2012 for treatment of head lice in anyone ages six months and older. Yourwellness Magazine explained that the ivermectin in the lotion works by attaching to the nerve and muscle cells of lice, which paralyses and kills them.
To find out more, visit the gateway to living well at http://www.yourwellness.com.